These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 4688656)
41. Regulation of the in vitro secondary cell-mediated cytotoxic response against syngeneic FBL-3 leukemia by macrophages. Igarashi T; Teranishi T; Rodrigues D; Yamamura Y Microbiol Immunol; 1980; 24(6):599-72. PubMed ID: 6968022 [TBL] [Abstract][Full Text] [Related]
42. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo. Green WR J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986 [No Abstract] [Full Text] [Related]
43. The role of cyclic AMP in the cytolytic activity of lymphocytes. Henney CS; Lichtenstein LM J Immunol; 1971 Aug; 107(2):610-2. PubMed ID: 4328013 [No Abstract] [Full Text] [Related]
44. Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells. Forman J; Möller G J Exp Med; 1973 Sep; 138(3):672-85. PubMed ID: 4269560 [TBL] [Abstract][Full Text] [Related]
45. A new model for leukemia-lymphoma metastasis: differential growth and rejection of murine lymphoid-leukemia cell lines in the bone marrow. Kamenov B; Kieran MW; Leigh JB; Greenberg AH; Longenecker BM Symp Fundam Cancer Res; 1983; 36():245-64. PubMed ID: 6679093 [No Abstract] [Full Text] [Related]
46. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells. Henney CS J Immunol; 1971 Dec; 107(6):1558-66. PubMed ID: 5000987 [No Abstract] [Full Text] [Related]
47. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells. Paciucci PA; Macphail S; Zarling JM; Bach FH J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969 [No Abstract] [Full Text] [Related]
48. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2. Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360 [TBL] [Abstract][Full Text] [Related]
49. T cells from naive mice suppress the in vitro cytotoxic response against endogenous Gross virus-induced tumor cells. Tilkin AF; Gomard E; Begue B; Levy JP J Immunol; 1984 Jan; 132(1):520-6. PubMed ID: 6228582 [TBL] [Abstract][Full Text] [Related]
50. Cytotoxic potential of mouse spleen cells on H-2 antibody-treated target cells. Kiessling R; Klein E J Exp Med; 1973 Feb; 137(2):527-32. PubMed ID: 4631140 [No Abstract] [Full Text] [Related]
51. Evidence for correlation between the antigenic specificity and charge of human IgG. A study of antibody-inducing lymphocyte mediated cell damage. MacLennan IC; Howard A Immunology; 1972 Jun; 22(6):1043-9. PubMed ID: 5032488 [TBL] [Abstract][Full Text] [Related]
52. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity. Evans R; Alexander P Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104 [TBL] [Abstract][Full Text] [Related]
53. Cytotoxic immune cells with specificity for defined soluble antigens. V. Interaction of antibody with the cytotoxic effector cells in immune or non-immune mouse spleen cells. Schirrmacher V; Rubin B; Pross H J Immunol; 1974 Jun; 112(6):2219-26. PubMed ID: 4856907 [No Abstract] [Full Text] [Related]
54. [Specificity of cell-mediated cytotoxicity. II. Cytotoxic lymphocytes after in vitro allogeneic sensitization in the H-2 system]. Schulze HA; Brock J Allerg Immunol (Leipz); 1983; 29(2):100-7. PubMed ID: 6224410 [TBL] [Abstract][Full Text] [Related]
55. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice. Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741 [TBL] [Abstract][Full Text] [Related]
56. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells. Green WR J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998 [TBL] [Abstract][Full Text] [Related]
57. Cytotoxic activity of lymphocytes. II. Studies on mechanism of lymphotoxin-mediated cytotoxicity. Walker SM; Lucas ZJ J Immunol; 1972 Dec; 109(6):1233-44. PubMed ID: 5086236 [No Abstract] [Full Text] [Related]
58. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment. Tomazic V; Ehrke MJ; Mihich E Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903 [TBL] [Abstract][Full Text] [Related]
59. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells. Olsson L; Kiger N; Kronstrom H Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655 [TBL] [Abstract][Full Text] [Related]
60. [Evolution of the cytotoxic activity of immune lymphocytes in response to a graft of leukemic cells in mice]. Leclerc JC; Gomard E; Pavie J; Lévy JP C R Acad Hebd Seances Acad Sci D; 1972 Feb; 274(8):1233-6. PubMed ID: 4624951 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]